|
|
Evaluation of risk factors for atherosclerotic plaque stability by intravascular ultrasound |
YAO Jing, XU Li-mei, YANG Xue |
Department of Cardiac Surgery, Shengjing Hospital of China Medical University, Shenyang 110003, China |
|
|
Abstract Objective: To explore the values of intravascular ultrasound in evaluating the stability of atherosclerotic plaques in patients with coronary heart disease. Methods: From February 2014 to December 2017, 122 patients with coronary heart disease were selected. All the patients were given intravascular ultrasound of coronary artery, the characteristics of ultrasound and the stability of atherosclerotic plaque were recorded, and the clinical data of the patients were investigated and the risk factors were evaluated. Results: There were 45 patients of unstable plaque were detected by intravascular ultrasound, and the detection rate was 36.9%. 21 patients of mild coronary artery stenosis were detected by intravascular ultrasound, 39 patients of moderate stenosis and 62 patients of severe stenosis, and the thickness of plaque, patch area and stenosis of unstable plaque were higher than those of stable plaque, and the difference were statistically significant(P<0.05). Two classified Logistic regression analysis showed that plaque thickness, plaque area, stenosis rate, Hcy and hs-CRP were independent risk factors for the occurrence of unstable plaques(P<0.05). Conclusion: The coronary artery intravascular ultrasound can effectively determine the stability of atherosclerotic plaque, and the characteristics of ultrasound are also the risk factors that affect the stability of plaque, and has certain reference value for predicting the occurrence of coronary heart disease.
|
Received: 28 August 2018
|
|
|
|
|
[1]Tang H, Zhu M, Zhao G, et al. Loss of CLOCK under high glucose upregulates ROCK1-mediated endothelial to mesenchymal transition and aggravates plaque vulnerability[J]. Atherosclerosis, 2018, 24(275): 58-67.
[2]徐亚兰. 超声检查冠心病患者心外膜脂肪层厚度与颈部血管弹性及其两者的相关性研究[J]. 临床研究,2018,26(4):138-139.
[3]Peng S, Xu LW, Che XY, et al. Atorvastatin Inhibits Inflammatory Response, Attenuates Lipid Deposition, and Improves the Stability of Vulnerable Atherosclerotic Plaques by Modulating Autophagy[J]. Front Pharmacol, 2018, 3(9): 438.
[4]Yang Y, Liu Y, Chen X, et al. 5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Alleviates Atherosclerosis via Enhancing Efferocytosis and Facilitating a Shift in the Th1/Th2 Balance Toward Th2 Polarization[J]. Cell Physiol Biochem, 2018, 47(1): 83-96.
[5]史海宏. 超声检查冠心病患者心外膜脂肪层厚度与颈部血管弹性及其两者的相关性研究[J]. 临床研究,2018,26(2):191-192.
[6]Chen X, Wang S, Lin L, et al. Drug effect of atorvastatin on middle cerebral atherosclerotic stenosis and high resolution NMR diagnosis[J]. Pak J Pharm Sci, 2018, 31(3(Special)): 1169-1173.
[7]庞志华,姚朱华. 老年冠心病患者经皮冠状动脉介入术后口服尼可地尔的临床疗效[J]. 中国老年学杂志,2018,38(2):331-333.
[8]吴思婧,赵迎新,郭永和,等. 冠心病合并糖尿病患者冠状动脉病变的血管腔内影像评价进展[J]. 心肺血管病杂志,2018,37(2):162-164.
[9]Wang F, Chen FF, Shang YY, et al. Insulin resistance adipocyte-derived exosomes aggravate atherosclerosis by increasing vasa vasorum angiogenesis in diabetic ApoE(-/-) mice[J]. Int J Cardiol, 2018, 15(265): 181-187.
[10]Tzanis G, Bonou M, Benetos G, et al. Thermal heterogeneity of carotid arteries as a novel biomarker in patients with diabetes mellitus assessed for coronary artery disease[J]. Int J Cardiol, 2018, 262(1): 20-24.
[11]齐疏影,李红,李响,等. 血管内超声指导介入治疗非ST段抬高型急性冠状动脉综合征患者冠状动脉分叉及开口病变的效果及预后[J]. 中国医药,2018,13(1):10-13.
[12]Zhou F, Tan Y, Chen XH, et al. Atorvastatin improves plaque stability in diabetic atherosclerosis through the RAGE pathway[J]. Eur Rev Med Pharmacol Sci, 2018, 22(4): 1142-1149.
[13]李松森,牛晓华,张守彦. 冠状动脉血管内超声在冠状动脉支架置入术中的应用价值[J]. 中国循证心血管医学杂志,2018,10(2):170-172;178.
[14]Shishikura D, Sidharta SL, Honda S, et al. The relationship between segmental wall shear stress and lipid core plaque derived from near-infrared spectroscopy[J]. Atherosclerosis, 2018, 275(5): 68-73.
[15]鲁爱粉,王恒亮,白广海,等. 血管内超声指导下改良CRUSH技术治疗左主干分叉病变的效果及安全性[J]. 实用临床医学,2017,18(5):16-19;封4.
[16]Nakanishi R, Alani A, Matsumoto S, et al. Changes in Coronary Plaque Volume: Comparison of Serial Measurements on Intravascular Ultrasound and Coronary Computed Tomographic Angiography[J]. Tex Heart Inst J, 2018, 45(2): 84-91.
[17]Boi A, Jamthikar AD, Saba L, et al. A Survey on Coronary Atherosclerotic Plaque Tissue Characterization in Intravascular Optical Coherence Tomography[J]. Curr Atheroscler Rep, 2018, 20(7): 33.
[18]袁方,刘从兵,何金朋. 2型糖尿病患者颈动脉内-中膜增厚对冠状动脉粥样硬化性心脏病的临床价值[J]. 实用医学影像杂志,2017,18(3):188-190.
[19]Siasos G, Sara JD, Zaromytidou M, et al. Local Low Shear Stress and Endothelial Dysfunction in Patients With Nonobstructive Coronary Atherosclerosis[J]. J Am Coll Cardiol, 2018, 71(19): 2092-2102.
[20]Kato Y, Iwata A, Futami M, et al. Impact of von Willebrand factor on coronary plaque burden in coronary artery disease patients treated with statins[J]. Medicine(Baltimore), 2018, 97(17): e0589.
[21]单培仁,蔡雪黎,项光泽,等. 血管内超声指导下冠状动脉支架术后即刻支架膨胀不全相关危险因素分析[J]. 浙江医学,2018,40(3):243-247.
[22]Shishikura D, Honda S, Andrews J, et al. Intravascular Ultrasound Studies of Plaque Progression and Regression: Impact of Lipid-Modifying Therapies[J]. Cardiol Clin, 2018, 36(2): 329-334.
[23]徐庆波,白广海,许晓茹,等. IVUS结合FFR指导冠脉临界病变介入治疗的价值[J]. 中国校医,2018,32(2):125-127.
[24]Ako J, Hibi K, Kozuma K, et al. Effect of alirocumab on coronary atheroma volume in Japanese patients with acute coronary syndromes and hypercholesterolemia not adequately controlled with statins: ODYSSEY J-IVUS rationale and design[J]. J Cardiol, 2018, 71(6): 583-589. |
|
|
|